CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Explore various methods to create passive income streams that can help you pay off debt. Start making money while you sleep!
22,771 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A California winery cofounder launches a program to cover living costs for families affected by cancer, challenging t...
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
As memory chip inventories weigh on the tech sector, the Dow shows remarkable resilience. This article breaks down wh...
American Express shares have fallen about 15% year-to-date to roughly $315 as of late February 2026, triggering a fre...
Oil-driven demand shifts could threaten McDonald’s traffic and same-store sales, even as its franchise-heavy model cu...
Gas prices are seeping into household budgets and market bets, with analysts warning that the pump’s visibility could...
Spring 2026 opens with renewed urgency as loan costs rise and builders push incentives. The market watches mortgage r...
The Federal Reserve is anticipated to keep the federal funds rate unchanged as Powell nears the end of his chair tenu...
Figure Technology Solutions delivered a powerful first quarter, as blockchain lending activity surged and revenue nea...
Hedge fund founder Jeffrey Gundlach warns the Fed won’t cut rates at the upcoming meeting amid stubborn inflation, hi...
Malaysia demands explanations from TikTok after a wave of offensive memes about the royal family. Regulators warn of ...